Edoras Investment Holdings Pte. Ltd, a promoter of Nephrocare Health Services Limited , confirmed that no encumbrance was created on the shares of the target company during the financial year ended March 31, 2026. The declaration was made in accordance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This confirmation applies to Edoras Investment Holdings Pte. Ltd and persons acting in concert with it.

The disclosure explicitly states that no encumbrance has been created, directly or indirectly, other than those already disclosed. The submission was addressed to BSE Limited and the National Stock Exchange of India Limited to ensure the information is placed on record. Nephrocare Health Services Limited is listed on the exchanges with the scrip code 544647 and symbol NEPHROPLUS.

The filing serves as an annual compliance requirement to assure the exchanges and shareholders regarding the status of the promoter's shareholding. By confirming the absence of new encumbrances, the promoter provides transparency regarding the financial leverage or charges against the shares of Nephrocare Health Services Limited for the specified period.

Nephrocare Health Services Ltd has closed its trading window for designated persons and their immediate relatives effective June 22, 2026, due to the existence of unpublished price sensitive information. The closure encompasses the financial results of the company for the quarter ending June 30, 2026. The trading window will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026.

The decision is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives. This measure ensures compliance with regulatory standards to prevent insider trading during the period of financial result finalization.

Key Dates and Details

The intimation regarding the closure has been made available on the company's official website. Kishore Kathri, the Company Secretary & Compliance Officer, signed the disclosure on June 19, 2026.